SEC Comment Letter for Sintx Technologies, Inc. (SINT) (CIK 0001269026) (SINT) — Oct 13, 2015
Sintx Technologies, Inc. (SINT) (CIK 0001269026)
Date: Oct. 13, 2015 · CIK: 0001269026 · Accession: 0000000000-15-049415
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-207289
Letter
Mail Stop 3030 October 13 , 2015 B. Sonny Bal , MD President and Chief Executive Officer Amedica Corporation 1885 West 2100 South Salt Lake City, Utah 84119
Re: Amedica Corporation Registration Statement on Form S-3 Filed October 5 , 2015 File No. 333-207289
Dear Dr. Bal:
This is to advise you that we have not reviewed and will not review your registration statement .
We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Act of 193 3 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disclosure, they are responsible for the accuracy and adequacy of the disclosures they have made.
In the event you request acceleration of the effective date of the pending regist ration statement, please provide a written statement from the company acknowledging that:
should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure i n the filing; and
the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please refer to Rules 460 a nd 461 regarding requests for acceleration . We will consider a written request for acceleration of the effective date of the registration statement as confirmation of the fact that those requesting acceleration are aware of their respective responsibiliti es under
B. Sonny Bal , MD Amedica Corporation October 13 , 2015 Page 2
the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed public offering of the registered securities .
You may contact Geoff Kruczek at (202) 551 -3641 with any questions.
Sincerely,
/s/ Geoff Kruczek for
Show Raw Text
Mail Stop 3030
October 13 , 2015
B. Sonny Bal , MD
President and Chief Executive Officer
Amedica Corporation
1885 West 2100 South
Salt Lake City, Utah 84119
Re: Amedica Corporation
Registration Statement on Form S-3
Filed October 5 , 2015
File No. 333-207289
Dear Dr. Bal:
This is to advise you that we have not reviewed and will not review your registration
statement .
We urge all persons who are responsible for the accuracy and adequacy of the disclosure
in the filing to be certain that the filing includes the information the Securities Act of 193 3 and
all applicable Securities Act rules require. Since the company and its management are in
possession of all facts relating to a company’s disclosure, they are responsible for the accuracy
and adequacy of the disclosures they have made.
In the event you request acceleration of the effective date of the pending regist ration
statement, please provide a written statement from the company acknowledging that:
should the Commission or the staff, acting pursuant to delegated authority, declare the
filing effective, it does not foreclose the Commission from taking any action with respect
to the filing;
the action of the Commission or the staff, acting pursuant to delegated authority, in
declaring the filing effective, does not relieve the company from its full responsibility for
the adequacy and accuracy of the disclosure i n the filing; and
the company may not assert staff comments and the declaration of effectiveness as a
defense in any proceeding initiated by the Commission or any person under the federal
securities laws of the United States.
Please refer to Rules 460 a nd 461 regarding requests for acceleration . We will consider a
written request for acceleration of the effective date of the registration statement as confirmation
of the fact that those requesting acceleration are aware of their respective responsibiliti es under
B. Sonny Bal , MD
Amedica Corporation
October 13 , 2015
Page 2
the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the proposed
public offering of the registered securities .
You may contact Geoff Kruczek at (202) 551 -3641 with any questions.
Sincerely,
/s/ Geoff Kruczek for
Amanda Ravitz
Assistant Director
Office of Electronics and Machinery
cc: Sam Gardiner , Esq.
David Marx, Esq.